CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 4 Other acquisition Chief Scientific Officer acquired 278,530 shares (other)
- 4 Open-market buy CEO and President bought 4,000 shares at $0.98 ($3,920)
- 3/A Insider 3/A
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy CEO and President bought 4,985 shares at $0.75 ($3,739)
- 4 Open-market buy Director bought 7,000 shares at $0.71 ($4,970)
- 4 Open-market buy Director bought 8,000 shares at $0.78 ($6,237)
- 10-KT Report 10-KT
- 424B3 Offering Prospectus
- 8-K Event Unregistered share sale
- SC TO-I/A Deal Tender Offer Statement by Issuer
- SC TO-I/A Deal Tender Offer Statement by Issuer
- 8-K Event Bylaws or fiscal year change
- SC TO-I/A Deal Tender Offer Statement by Issuer
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC TO-I/A Deal Tender Offer Statement by Issuer
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
Page 41 of 47 · 929 filings